SFM
TGTX icon

Sphera Funds Management’s TG Therapeutics TGTX Stock Holding History

Sphera Funds Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-60,000
Closed -$563K – 144
2014
Q2 		$563K Sell
60,000
-140,000
-70% -$895K 0.14% 85
2014
Q1 		$1.38M Buy
+200,000
New +$1.18M 0.32% 67

Other funds holding TGTX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sphera Funds Management's TGTX Position: Q3 2014 in Review

Sphera Funds Management sold out of TG Therapeutics (TGTX) in Q3 2014, closing a stake of 60,000 shares — an estimated $563K sold.

Sphera Funds Management first reported a position in TGTX in Q1 2014 and held it in 2 quarters. The position peaked at $1.38M in Q1 2014. 66 funds tracked by Wall St. Rank hold TGTX as of Q3 2014.

  • Sphera Funds Management reported no remaining TG Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Sphera Funds Management sold 60,000 TG Therapeutics shares in Q3 2014, an estimated $563K.
  • Sphera Funds Management first reported a position in TG Therapeutics in Q1 2014 and held it in 2 quarters.
  • Sphera Funds Management's TG Therapeutics position peaked at $1.38M in Q1 2014.
  • 66 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2014.

Based on Sphera Funds Management's 13F filing for Q3 2014, filed 13 Nov 2014.